HUT70972A - Protein compound capable of inhibiting tumoral growth - Google Patents

Protein compound capable of inhibiting tumoral growth

Info

Publication number
HUT70972A
HUT70972A HU9402317A HU9402317A HUT70972A HU T70972 A HUT70972 A HU T70972A HU 9402317 A HU9402317 A HU 9402317A HU 9402317 A HU9402317 A HU 9402317A HU T70972 A HUT70972 A HU T70972A
Authority
HU
Hungary
Prior art keywords
compound capable
protein compound
tumoral growth
inhibiting
inhibiting tumoral
Prior art date
Application number
HU9402317A
Other languages
Hungarian (hu)
Other versions
HU9402317D0 (en
Inventor
Aldo Mancini
Original Assignee
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITRM920161A external-priority patent/IT1255038B/en
Priority claimed from IT92RM716 external-priority patent/IT1262997B/en
Application filed by Ist Naz Stud Cura Dei Tumori filed Critical Ist Naz Stud Cura Dei Tumori
Publication of HU9402317D0 publication Critical patent/HU9402317D0/en
Publication of HUT70972A publication Critical patent/HUT70972A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU9402317A 1992-03-09 1993-03-08 Protein compound capable of inhibiting tumoral growth HUT70972A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM920161A IT1255038B (en) 1992-03-09 1992-03-09 Mammal cell line and conditioned culture medium
IT92RM716 IT1262997B (en) 1992-09-30 1992-09-30 New protein homologous to human heat shock P27 protein - is obtd. from liposarcoma cells, used for treating oestrogen-dependent epithelial tumours

Publications (2)

Publication Number Publication Date
HU9402317D0 HU9402317D0 (en) 1994-10-28
HUT70972A true HUT70972A (en) 1995-11-28

Family

ID=26332011

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9402317A HUT70972A (en) 1992-03-09 1993-03-08 Protein compound capable of inhibiting tumoral growth

Country Status (7)

Country Link
EP (1) EP0630404A1 (en)
KR (1) KR950700412A (en)
CN (1) CN1078494A (en)
CA (1) CA2130089A1 (en)
FI (1) FI944102A0 (en)
HU (1) HUT70972A (en)
WO (1) WO1993018147A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744155A (en) * 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
US5750119A (en) * 1994-01-13 1998-05-12 Mount Sinai School Of Medicine Of The City University Of New York Immunotherapeutic stress protein-peptide complexes against cancer
US5997873A (en) 1994-01-13 1999-12-07 Mount Sinai School Of Medicine Of The City University Of New York Method of preparation of heat shock protein 70-peptide complexes
US5961979A (en) 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
US5837251A (en) 1995-09-13 1998-11-17 Fordham University Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
US5935576A (en) 1995-09-13 1999-08-10 Fordham University Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
US5985270A (en) * 1995-09-13 1999-11-16 Fordham University Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
US6017540A (en) 1997-02-07 2000-01-25 Fordham University Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
US5830464A (en) * 1997-02-07 1998-11-03 Fordham University Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
US5948646A (en) 1997-12-11 1999-09-07 Fordham University Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
EP2295065B1 (en) 1998-02-20 2013-10-09 The University of Miami Modified heat shock protein-antigenic peptide complex
US7449557B2 (en) 2000-06-02 2008-11-11 University Of Connecticut Health Center Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
WO2003015712A2 (en) 2001-08-20 2003-02-27 University Of Connecticut Health Center Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin
ITMI20020404A1 (en) * 2002-02-28 2003-08-28 Ist Naz Stud Cura Dei Tumori NEW MANGANESE SUPEROXIDE HUMAN DISMUTATION
DK2257301T3 (en) 2008-03-03 2014-04-28 Univ Miami Immunotherapy based on allogeneic cancer cells.
WO2009117116A2 (en) 2008-03-20 2009-09-24 University Of Miami Heat shock protein gp96 vaccination and methods of using same
WO2016127015A1 (en) 2015-02-06 2016-08-11 Heat Biologics, Inc. Vector co-expressing vaccine and costimulatory molecules
WO2018071405A1 (en) 2016-10-11 2018-04-19 University Of Miami Vectors and vaccine cells for immunity against zika virus
US11548930B2 (en) 2017-04-04 2023-01-10 Heat Biologics, Inc. Intratumoral vaccination

Also Published As

Publication number Publication date
KR950700412A (en) 1995-01-16
EP0630404A1 (en) 1994-12-28
WO1993018147A1 (en) 1993-09-16
CN1078494A (en) 1993-11-17
CA2130089A1 (en) 1993-09-16
FI944102A (en) 1994-09-07
HU9402317D0 (en) 1994-10-28
FI944102A0 (en) 1994-09-07

Similar Documents

Publication Publication Date Title
HU9402317D0 (en) Protein compound capable of inhibiting tumoral growth
ZA943612B (en) Inhibition of hair growth
ZA943611B (en) Inhibition of hair growth
ZA961600B (en) Inhibition of hair growth
EP0820296A4 (en) Analogs of growth hormone-releasing factor
SG44630A1 (en) Preparation of substituted guanidines
ZA937353B (en) Taste masking of thymol
AU3584093A (en) Diaminopyridine compounds for the inhibition of protein glycosylation
AU6728690A (en) Method for inhibiting the growth of salmonella
IL107706A0 (en) Fungicidal derivatives of 2-alkoxy-2-imidazolin-5-ones
GB9413935D0 (en) Use of maramyl peptide compounds
AU2504192A (en) Protein kinase c inhibition and novel compound balanol
EP0557890A3 (en) Method for the growth of epitaxial metal-insulator-metal-semiconductor structures
AU1783092A (en) Inhibitors of protein kinase c function
AU1304895A (en) Peptides to overcome inhibition of nerve growth
PL315172A1 (en) Novel gene inhibiting growth of neoplasms
EP0796095A4 (en) Methods of inhibiting growth hormone effects
EP0494369A3 (en) Sterilization of growth factors
GB2275266A8 (en) Preparation of 2-methyl-3-aminobenzotrifluoride
AU1252492A (en) Stimulation of hair growth by phospholipids
EP0562624A3 (en) Stabilization of functional proteins
AU4245693A (en) Growth of diamond crystals
EP0553954A3 (en) Preparation of tetramethyldiamino-polyoxyethylenes
KR950000006Y1 (en) Fastenings of sport-shoes
GB9225928D0 (en) Growth factor

Legal Events

Date Code Title Description
DFD9 Temporary prot. cancelled due to non-payment of fee